Breaking News Instant updates and real-time market news.

AMD

AMD

$16.31

0.46 (2.90%)

, PBR

Petrobras

$9.67

-0.115 (-1.18%)

07:35
06/14/18
06/14
07:35
06/14/18
07:35

Unusual call flow in option market yesterday

Notable call activity was cited Wednesday in AMD (AMD), Petrobras (PBR), Chesapeake (CHK), Electronic Arts (EA), Marathon Oil (MRO), PG&E (PCG), SunPower (SPWR), KKR (KKR), and GlaxoSmithKline (GSK).

AMD

AMD

$16.31

0.46 (2.90%)

PBR

Petrobras

$9.67

-0.115 (-1.18%)

CHK

Chesapeake

$4.76

-0.045 (-0.94%)

EA

Electronic Arts

$143.30

3.5 (2.50%)

MRO

Marathon Oil

$21.47

0.1 (0.47%)

PCG

PG&E

$39.39

0.1 (0.25%)

SPWR

SunPower

$7.96

0.12 (1.53%)

KKR

KKR

$23.63

0.4 (1.72%)

GSK

GlaxoSmithKline

$41.15

-0.065 (-0.16%)

  • 14

    Jun

  • 15

    Jun

  • 26

    Jun

  • 28

    Jun

  • 25

    Jul

  • 02

    Aug

AMD AMD
$16.31

0.46 (2.90%)

05/18/18
05/18/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. MasterCard (MA) initiated with a Neutral at UBS. 2. AMD (AMD) initiated with an Outperform at Cowen while Intel (INTC) was initiated with a Market Perform. 3. Synthetic Biologics (SYN) initiated with a Buy at H.C. Wainwright. 4. Amneal Pharmaceuticals (AMRX) initiated with a Neutral at JPMorgan. 5. Apollo Commercial (ARI) initiated with a Buy at Deutsche Bank. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/18/18
COWN
05/18/18
INITIATION
Target $18
COWN
Outperform
Cowen starts AMD at Outperform, sees potential for taking share from Intel
As reported previously, Cowen analyst Matthew Ramsay initiated AMD (AMD) with an Outperform rating. The analyst believes the company's 7nm products will gain market share versus Intel's (INTC) 10nm silicon in 2019 /2020. Ramsay has a $18 price target on AMD shares.
05/17/18
COWN
05/17/18
INITIATION
Target $18
COWN
Outperform
AMD initiated with an Outperform at Cowen
Cowen initiated AMD with an Outperform and $18 price target.
06/01/18
STFL
06/01/18
NO CHANGE
Target $17
STFL
Buy
AMD price target raised to $17 from $14 at Stifel
Stifel analyst Kevin Cassidy increased his estimates for AMD following his review of the processor market, stating that the company continuing to meet its product introduction milestones is increasing their customers' confidence in adopting AMD CPUs and GPUs. The analyst, who believes AMD's EPYC server CPU is winning server designs, raised his price target on AMD shares to $17 from $14 and keeps a Buy rating on the stock.
PBR Petrobras
$9.67

-0.115 (-1.18%)

06/11/18
RAJA
06/11/18
UPGRADE
RAJA
Market Perform
Petrobras upgraded to Market Perform from Underperform at Raymond James
06/11/18
06/11/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. UMC (UMC) upgraded to Market Perform from Underperform at Bernstein with analyst Mark Li saying he believes the company will deliver a better capital return. 2. Petrobras (PBR) upgraded to Market Perform from Underperform at Raymond James with analyst Pavel Molchanov saying the government's "dramatic intervention" in late May to slash diesel prices in response to a national trucker strike is largely reflected in valuation. 3. Apache (APA) upgraded to Buy from Hold at Argus with analyst Bill Selesky citing the impact of rising crude oil prices as well as the management's strategy of allocating nearly 70% of its FY18 capital spending program to production in the Permian basin. 4. Match Group (MTCH) upgraded to Buy from Hold at Jefferies with analyst Brent Thill saying a survey of 600 online daters shows many users do not wish to commingle dating with social media. 5. First Data (FDC) upgraded to Buy from Neutral at Goldman Sachs with analyst James Schneider saying despite "choppy" fundamentals, the company's revenue growth is poised to improve. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/08/18
06/08/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Petrobras (PBR) downgraded to Neutral from Buy at UBS with analyst Luiz Carvalho citing reduced visibility on its long-term pricing policy after the company recently reduced prices, which significantly lowered the chances of the company selling its refining assets, keeping it a monopoly, and exposed it to possible interference depending on the government's policy approach and macro conditions. 2. Domino's Pizza (DPZ) downgraded to Hold from Buy at Maxim with analyst Stephen Anderson saying the company's comp performance and market share gains in the U.S., accelerated unit development worldwide, and mostly favorable cost outlook warrant a premium multiple, but believes these positives have been priced into shares. 3. Noble Energy (NBL) downgraded to Hold from Buy at Tudor Pickering. 4. Sientra (SIEN) downgraded to Hold from Buy at Maxim with analyst Anthony Vendetti saying that while he is optimistic on Sientra's long-term prospects, the valuation is significantly ahead of peer averages and the stock price has exceeded his 12-month target. 5. Quanex (NX) downgraded to Neutral from Buy at Sidoti. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/11/18
06/11/18
UPGRADE

Market Perform
Petrobras upgraded to Market Perform on valuation at Raymond James
As previously reported, Raymond James upgraded Petrobras to Market Perform from Underperform. Analyst Pavel Molchanov said the goernement's "dramatic intervention" in late May to slash diesel prices in response to a national trucker strike is largely reflected in valuation.
CHK Chesapeake
$4.76

-0.045 (-0.94%)

03/07/18
UBSW
03/07/18
INITIATION
Target $2.8
UBSW
Sell
Chesapeake initiated with a Sell at UBS
UBS analyst Lloyd Byrne started Chesapeake Energy with a Sell rating and $2.80 price target.
03/26/18
BERN
03/26/18
DOWNGRADE
BERN
Underperform
Chesapeake downgraded to Underperform from Market Perform at Bernstein
03/27/18
03/27/18
DOWNGRADE

Underperform
Chesapeake downgraded to Underperform at Bernstein
As previously reported, Bernstein analyst Bob Brackett downgraded Chesapeake to Underperform from Market Perform as he believes gas levered names, particularly those with significant debt loads, are likely to struggle as gas prices compress cash margins.
04/17/18
SBSH
04/17/18
DOWNGRADE
Target $2
SBSH
Sell
Chesapeake downgraded to Sell from Neutral at Citi
Citi analyst Robert Morris downgraded Chesapeake Energy to Sell and lowered his price target for the shares to $2 from $5. The analyst made a series of downgrades after lowering his 2018 composite spot natural gas price forecast to $2.75/MMBtu from $3.00/MMBtu, and for 2019 to $2.60/MMBtu from $3.35/MMBtu. He sees higher oil prices adversely impacting the outlook for U.S. natural gas prices.
EA Electronic Arts
$143.30

3.5 (2.50%)

06/11/18
PIPR
06/11/18
NO CHANGE
Target $148
PIPR
Overweight
Piper confident in Overweight rating on EA ahead of Fortnite-like release
Electronic Arts (EA) over the weekend announced that a Fortnite-like battle royale mode will be coming to Battlefield V, which ships in October, Piper Jaffray analyst Michael Olson tells investors in a research note. Additionally, EA confirmed that a subscription service for frontline titles is coming, albeit only on PC to start, the analyst adds. Olson sees "many potential catalysts" over the next six months for shares of Electronic Arts. He is confident in his Overweight rating and $148 price target on the shares. Electronic Arts trades at a discounted valuation to closest comp Activision Blizzard (ATVI), Olson points out.
06/06/18
NEED
06/06/18
NO CHANGE
Target $80
NEED
Buy
Activision Blizzard's Buy rating reiterated at Needham following channel checks
After speaking with a senior executive that specializes in physical distribution of video games, Needham analyst Laura Martin tells investors in a research note that Activision Blizzard (ATVI) physical game sales quotas for its key distributors are about flat year-over-year, even though many gamers download key shooter games at midnight the day of release, adding that demand for physical games from Electronic Arts (EA) is "more spread out," causing FIFA and Madden gamers to wait. Additionally, she says Fortnite negatively impacted store sales of all other titles for 2-3 weeks, "and is not back to normal," and that Activision's eSports strategy with Overload will make more money for the company, but that Electronic Arts' fan-focused eSports strategy will fuel higher game sales and longer life spans playing the games. Further, Martin says the senior executive believes EA's strategy of developing an annuity stream is "a great one," and believes Activision should adopt a similar strategy. Martin keeps a Buy rating and $80 price target on Activision Blizzard shares.
06/11/18
BARD
06/11/18
NO CHANGE
BARD
Outperform
Video games emerging as largest segment of media/entertainment, says Baird
Baird analyst Colin Sebastian said video games are emerging as the largest segment of media and entertainment globally. The analyst calls the segment a "must-own" group and tells investors to "take your pick" in either Activision Blizzard (ATVI), Electronic Arts (EA), or Take-Two Interactive (TTWO). The analyst cited secular growth trends, including recurring digital revenues, millennial media consumption, mobile monetization, emerging esports, and intermediate-term development of advanced streaming services.
05/25/18
ARGS
05/25/18
NO CHANGE
ARGS
Hold
Electronic Arts valuation still above its peer group, says Argus
Argus analyst Joseph Bonner is raising his FY19 EPS view on Electronic Arts to $4.99 from $4.78 after its latest earnings, saying the company shows a double-digit profit growth and mid-single digit revenue growth trend. The analyst points to the management's expectations of back-end loaded FY19 based on the timing of expected blockbuster games releases however, keeping his Hold rating on Electronic Arts. Bonner also notes that the stock price is trading near the high end of its recent range, while its forward enterprise value/sales multiple of 6.3-times is 40% above the peer average.
MRO Marathon Oil
$21.47

0.1 (0.47%)

06/08/18
TUDR
06/08/18
UPGRADE
TUDR
Buy
Marathon Oil upgraded to Buy from Hold at Tudor Pickering
Tudor Pickering analyst Matthew Portillo upgraded Marathon Oil to Buy from Hold.
06/08/18
06/08/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. ConocoPhillips (COP) upgraded to Outperform from Market Perform at Bernstein with analyst Bob Brackett saying the company's "stalwart global portfolio" and Brent pricing helps insulate it from Permian congestion impacting other E&Ps. 2. DexCom (DXCM) upgraded to Overweight from Neutral at JPMorgan with analyst Robbie Marcus saying glucose measurement is becoming an essential tool for patients and DexCom, with the launch of the G6, is the "clear market leader" from a technological standpoint. 3. Penn National (PENN) reinstated with an Overweight from Neutral at JPMorgan with analyst Joseph Gref saying he sees a favorable setup for the shares given an "attractive regional gaming landscape" and the company's margin improvement initiatives. 4. Marathon Oil (MRO) upgraded to Buy from Hold at Tudor Pickering. 5. Quest Diagnostics (DGX) upgraded to Outperform from Market Perform at William Blair with analyst Amanda Murphy citing the recent UnitedHealthcare (UNH) contract change and positive secular trends for larger labs. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/07/18
UBSW
03/07/18
INITIATION
Target $16
UBSW
Neutral
Marathon Oil initiated with a Neutral at UBS
UBS analyst Lloyd Byrne started Marathon Oil with a Neutral rating and $16 price target.
03/26/18
JPMS
03/26/18
UPGRADE
Target $20
JPMS
Overweight
Marathon Oil upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Arun Jayaram upgraded Marathon Oil to Overweight with a $20 price target. The analyst believes Marathon offers a "unique combination" of free cash flow growth at an attractive valuation. He thinks the current valuation discount relative to peers is not justified.
PCG PG&E
$39.39

0.1 (0.25%)

06/11/18
WELS
06/11/18
NO CHANGE
WELS
CAL FIRE reports an incrementally negative for PG&E, says Wells Fargo
Wells Fargo analyst Neil Kalton notes that CAL FIRE issued reports on the causes of an additional 12 fires related to the 2017 Northern California wildfires, and determined that PG&E's (PCG) infrastructure was involved in all 12 fires and that there was evidence that the company violated state laws in 8 fires. The analyst views the CAL FIRE reports as an incrementally negative development as it further casts PG&E in a bad light. While he thinks PG&E's shares reflect an overly onerous outcome, Edison International (EIX) remains his preferred play for a California regulatory recovery. Kalton reiterates a Market Perform rating on PG&E shares and an Outperform rating on Edison's stock, while lowering his price target on the former to $46 from $48 and on the latter to $72 from $74.
06/11/18
MSCO
06/11/18
NO CHANGE
Target $62
MSCO
Overweight
Morgan Stanley says PG&E won't realize 'anywhere close' to all NorCal fire blame
After Cal Fire on Friday issued reports on twelve of the Northern California wildfires in October 2017, Morgan Stanley analyst Stephen Byrd estimated PG&E is likely not liable for about 34% of damages reported on to date, while the report on the largest fire has not yet been issued. Among the three largest fires assessed to date, one had no reported PG&E violations, one had a reported violation, and one has a "complex fact pattern," stated Byrd, who also noted that the largest of the NorCal fires - Tubbs - had an incident report "quite different" from the other incident reports issued by the company. Byrd, who believes it is unlikely PG&E shareholders will realize "anywhere close to 100% of both causation and negligence" for all 21 NorCal wildfires, keeps an Overweight rating on PG&E shares.
06/11/18
GUGG
06/11/18
NO CHANGE
Target $35
GUGG
Sell
PG&E allegedly violated law in majority of CA fires thus far, says Guggenheim
Guggenheim analyst Shahriar Pourreza noted that Cal Fire's second report found that PG&E's equipment was responsible for multiple fires in Northern California during the October 2017 wildfires, which means that the utility has been found to allegedly violate state law in eleven of sixteen fires thus far. Given the findings, the analyst questions whether the matter of "inverse condemnation" is even an issue at this point. "All signs seem to point" to PG&E "being imprudent operators in the majority of instances," meaning it should assume liability, said Pourreza. He maintains a Sell rating on PG&E shares, calling for potentially further downside, especially when the Tubbs investigation is released.
06/11/18
DBAB
06/11/18
NO CHANGE
DBAB
Buy
CalFire referring to district attorneys a negative, says Deutsche Bank
On Friday after the close, CalFire announced the results of another 12 investigations into the October 2017 Northern California fires. This brings the total number of completed investigations to 16 since the first four reports were released ahead of Memorial Day weekend, Deutsche Bank analyst Jonathan Arnold tells investors in a research note. The analyst notes that of 12 new reports, PG&E lines were found to have been involved in starting all or most of them. He sees, however, some confusion between the press release and report which may raise some questions as to whether the Nuns Fire might in fact have been started by a customer's lines. CalFire referring eight of the 12 new reports to relevant county district attorney offices was the most negative individual data point in Friday's reports, Arnold contends. On the positive side of the ledger, CalFire did not allege violations for the Redwood Fire or the Nuns Fire, the analyst adds. He keeps a Buy rating on the shares of PG&E.
SPWR SunPower
$7.96

0.12 (1.53%)

06/11/18
BARD
06/11/18
DOWNGRADE
Target $7
BARD
Neutral
SunPower downgraded to Neutral at Baird
As reported previously, Baird analyst Ben Kallo downgraded SunPower to Neutral from Outperform as he believes the stock is too difficult to own in the current market. The analyst said he still likes the management team and execution, but he believes it will be challenging for the company's premier product to command higher average selling prices if an oversupply environment were to materialize. Kallo lowered his price target to $7 from $10 on SunPower shares.
06/11/18
BARD
06/11/18
DOWNGRADE
BARD
Neutral
SunPower downgraded to Neutral from Outperform at Baird
04/23/18
04/23/18
DOWNGRADE
Target $7

Underperform
SunPower downgraded to Underperform on tariff concerns at BofA/Merrill
As previously reported, BofA/Merrill downgraded SunPower to Underperform from Neutral and cut its price target to $7 from $8.50. Analyst Julien Dumoulin-Smith has increased concerns regarding the impact on sales and margin from import tariffs on SunPower's premium business and increased concerns on an EBITDA recovery. The analyst said shares are fully valued and a further "paring back" of the business in Q1.
04/23/18
BOFA
04/23/18
DOWNGRADE
BOFA
Underperform
SunPower downgraded to Underperform from Neutral at BofA/Merrill
KKR KKR
$23.63

0.4 (1.72%)

06/05/18
RHCO
06/05/18
NO CHANGE
Target $90
RHCO
Buy
Amedisys's robust free cash flow 'a good thing,' says SunTrust
SunTrust analyst David MacDonald said he is "bullish" on Amedisys (AMED) following the repurchase of 2.4M shares from KKR (KKR), telling investors in a research note that the company's pristine balance sheet, strong free cash flow and expected near-term upsizing of the credit facility should give Amedisys plenty of dry power to ramp M&A activity. MacDonald raised his price target to $90 from $85 and maintained a Buy rating on the stock.
06/05/18
SPHN
06/05/18
NO CHANGE
Target $78
SPHN
Equal Weight
Amedisys buying back shares from KKR a 'win-win,' says Stephens
Stephens analyst Dana Hambly called Amedisys' (AMED) repurchase of about 2.4M of its common shares from KKR (KKR) a "creative way to deploy excess capital" and create shareholder value while also returning capital to KKR and not impacting Amedisys' ability to pursue M&A. He also noted that the company is in advanced talks to increase borrowing to support M&A. Hambly raised his 2019 EPS estimate by 6% to account for the buybacks and raised his price target on Amedisys to $78 from $73, though he keeps an Equal Weight rating on the stock, citing valuation.
05/16/18
SBSH
05/16/18
UPGRADE
Target $27
SBSH
Buy
KKR upgraded to Buy from Neutral at Citi
Citi analyst William Katz upgraded KKR to Buy and raised his price target for the shares to $27 from $23.50. The analyst believes the company's C-Corp conversion will increase relevance of the sector and raise the absolute upside for KKR. His higher price target incorporates increased balance sheet value, lower cost of capital to discount performance fees, and tax benefits related to the C Corp conversion.
05/16/18
05/16/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Urban Outfitters (URBN) upgraded to Neutral from Sell at MKM Partners with analyst Roxanne Meyer citing her expectations of a sales and margin recovery in the second half, with fourth quarter commentary suggesting improving trends after the company's worse than expected performance in 2017. 2. AMD (AMD) upgraded to Neutral from Negative at Susquehanna with analyst Christopher Rolland saying Ethereum prices have doubled in the last month, driving a "modest" reacceleration in GPU purchases, while price hikes have "destroyed value proposition" of a rival Ethereum ASIC. 3. TripAdvisor (TRIP) upgraded two notches to Outperform from Underperform at Macquarie with analyst Matthew Brooks saying TripAdvisor raised their EBITDA forecast to up from flat, and now believes it could grow above 20% in 2018, with a margin rise for the first time since 2011. 4. KKR (KKR) upgraded to Buy from Neutral at Citi with analyst William Katz saying he believes the company's C-Corp conversion will increase relevance of the sector and raise the absolute upside for KKR. 5. Chipotle (CMG) upgraded to Buy from Hold at Argus with analyst John Staszak saying the current valuation does not adequately "reflect prospects for accelerating same-store sales and earnings growth as the company continues its multiyear recovery." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
GSK GlaxoSmithKline
$41.15

-0.065 (-0.16%)

04/04/18
04/04/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Transocean (RIG) upgraded to Buy from Hold at HSBC. 2. GlaxoSmithKline (GSK) upgraded to Outperform from Neutral at Exane BNP Paribas. 3. BHP Billiton (BHP) upgraded to Sector Perform from Underperform at RBC Capital and to Buy from Neutral at Citi. 4. Boston Beer (SAM) upgraded to Market Perform from Underperform at Cowen with analyst Vivien Azer citing strong Nielsen data in the non-beer category. 5. EnLink Midstream Partners (ENLK) upgraded to Overweight from Neutral at JPMorgan with analyst Jeremy Tonet saying he reduced his distribution growth expectations given the elevated cost of equity, but views the current 11.5% yield as sustainable. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/25/18
WELS
04/25/18
NO CHANGE
WELS
Market Perform
Glaxo comments on Advair have negative read through for Mylan, says Wells Fargo
Noting that GlaxoSmithKline (GSK) said it now expects branded Advair sales to decline 30% this year, even excluding the impact of a generic, Wells Fargo analyst David Maris said the news has a negative read through for Mylan (MYL) given that its generic Advair is one of the company's highest profile pipeline items. While Advair will be a good generic opportunity, it represents "a fraction of what some might have previously believed," said Maris, who has a Market Perform rating on Mylan shares.
06/13/18
MSCO
06/13/18
NO CHANGE
MSCO
HHS 'smoke signals' worth noting for drugmakers, says Morgan Stanley
After HHS Secretary Alex Azar spoke at a two-hour Senate hearing, Morgan Stanley analyst David Risinger noted that Azar suggested that U.S. drug pricing needs to move to a system without rebates and said payments from drugmakers to PBMs should be eliminated. In listing four HHS actions that could hurt manufacturers, Risinger pointed out that Azar said he is interested in removing 100% cap on Medicaid rebates; he would like to adjust the Part D protected drug classes so that plans can extract rebates from manufacturers; HHS wants to require manufacturers to disclose drug list prices in TV ads; and HHS is focused on transitioning Part B to lower-priced private sector management. In summary, the analyst said that for drugmakers there was "no fire, but smoke signals worth noting." Publicly traded large-cap drugmakers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).
05/16/18
SPHN
05/16/18
INITIATION
Target $16
SPHN
Overweight
Codexis initiated with an Overweight at Stephens
Stephens analyst Drew Jones started Codexis (CDXS) with an Overweight rating and $16 price target, stating that the company's CodeEvolver platform technology has been sought by pharma partners Merck (MRK), GlaxoSmithKline (GSK) and Nestle (NSRGY) and he expects continued deeper adoption from other major industry players.

TODAY'S FREE FLY STORIES

CDTI

CDTi

$0.34

0.01 (3.08%)

18:15
09/21/18
09/21
18:15
09/21/18
18:15
Hot Stocks
CDTi sees September 21 as effective date of reverse stock split »

CDTi Advanced Materials…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DUK

Duke Energy

$79.82

-0.81 (-1.00%)

18:08
09/21/18
09/21
18:08
09/21/18
18:08
Hot Stocks
Duke Energy restored nearly 1.8M outages in NC, SC during past week »

Duke Energy crews today…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 02

    Oct

  • 03

    Oct

  • 04

    Oct

  • 11

    Nov

JNJ

Johnson & Johnson

$142.85

0.85 (0.60%)

18:01
09/21/18
09/21
18:01
09/21/18
18:01
Hot Stocks
Johnson & Johnson's Janssen discloses phase 3 study results of Esketamine »

The Janssen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 28

    Oct

UAL

United Continental

$89.94

0.8 (0.90%)

17:39
09/21/18
09/21
17:39
09/21/18
17:39
Periodicals
United pilots refuse contract changes on regional routes, Reuters says »

United Airlines pilots…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

XLE

Energy Select Sector SPDR

$75.11

0.5132 (0.69%)

, XLU

Utilities SPDR

$53.04

0.2049 (0.39%)

17:36
09/21/18
09/21
17:36
09/21/18
17:36
General news
Week ending ETF Scorecard: Materials outperform, Utlilites slump »

S&P500 SECTORS:…

XLE

Energy Select Sector SPDR

$75.11

0.5132 (0.69%)

XLU

Utilities SPDR

$53.04

0.2049 (0.39%)

IYR

DJ US Real Estate Index Fund

$81.88

-0.06 (-0.07%)

XLP

Consumer Staples Sector SPDR

$55.02

0.1285 (0.23%)

XLY

Consumer Discretionary Sector SPDR

$116.98

-0.4288 (-0.37%)

XLB

S&P Select Materials SPDR

$60.54

-0.1312 (-0.22%)

XLF

Financial Select Sector

$28.73

-0.1175 (-0.41%)

XLV

Health Care Select Sector SPDR

$94.26

0.1571 (0.17%)

XLK

Technology Select Sector SPDR

$74.68

-0.2056 (-0.27%)

XLI

Industrial Select Sector SPDR

$79.71

0.2338 (0.29%)

GLD

SPDR Gold Trust

$113.48

-0.77 (-0.67%)

SLV

iShares Silver Trust

$13.44

-0.01 (-0.07%)

USO

United States Oil Fund

$14.95

0.145 (0.98%)

UNG

United States Natural Gas Fund

$24.60

0.235 (0.96%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$86.24

0.05 (0.06%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$114.72

0.04 (0.03%)

TLT

iShares 20+ Year Treasury Bond Fund

$117.12

-0.02 (-0.02%)

IEF

iShares 7-10 Year Treasury Bond ETF

$101.00

0.03 (0.03%)

SHY

iShares 1-3 Year Treasury Bond

$83.05

0.02 (0.02%)

IWD

iShares Russell 1000 Value

$129.51

0.13 (0.10%)

IWF

iShares Russell 1000 Growth

$155.30

-0.55 (-0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OHGI

One Horizon Group

$0.18

-0.0088 (-4.63%)

17:34
09/21/18
09/21
17:34
09/21/18
17:34
Syndicate
Breaking Syndicate news story on One Horizon Group »

One Horizon Group files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYTX

Cytori Therapeutics

$0.41

-0.033 (-7.38%)

17:31
09/21/18
09/21
17:31
09/21/18
17:31
Syndicate
Breaking Syndicate news story on Cytori Therapeutics »

Cytori Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEM

Newmont Mining

$31.56

0.05 (0.16%)

17:22
09/21/18
09/21
17:22
09/21/18
17:22
Syndicate
Breaking Syndicate news story on Newmont Mining »

Newmont Mining files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 25

    Oct

CB

Chubb

$139.87

-0.05 (-0.04%)

17:22
09/21/18
09/21
17:22
09/21/18
17:22
Hot Stocks
Chubb CEO Greenberg sells $8.6M in common stock »

Chubb CEO Evan Greenberg…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VTVT

vTv Therapeutics

$0.80

0.0096 (1.21%)

17:21
09/21/18
09/21
17:21
09/21/18
17:21
Hot Stocks
vTv says FDA advised that azeliragon efficacy be shown in at least 2 trials »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VYGR

Voyager Therapeutics

$18.21

-0.27 (-1.46%)

17:17
09/21/18
09/21
17:17
09/21/18
17:17
Hot Stocks
Breaking Hot Stocks news story on Voyager Therapeutics »

Armistice Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNRC

Generac

$57.99

-0.02 (-0.03%)

17:16
09/21/18
09/21
17:16
09/21/18
17:16
Hot Stocks
Generac announces new $250M share repurchase program »

The company announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GBNK

Guaranty Bancorp

$30.20

-0.5 (-1.63%)

, IBTX

Independent Bank

$67.60

-1.15 (-1.67%)

17:13
09/21/18
09/21
17:13
09/21/18
17:13
Conference/Events
Independent Bank to host special shareholder meeting »

Special Shareholder…

GBNK

Guaranty Bancorp

$30.20

-0.5 (-1.63%)

IBTX

Independent Bank

$67.60

-1.15 (-1.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

HRS

Harris

$164.33

1.685 (1.04%)

17:13
09/21/18
09/21
17:13
09/21/18
17:13
Hot Stocks
Harris awarded $255.4M Department of Defense contract »

Harris Corp has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PMBC

Pacific Mercantile Bancorp

$9.25

-0.5 (-5.13%)

17:10
09/21/18
09/21
17:10
09/21/18
17:10
Hot Stocks
Breaking Hot Stocks news story on Pacific Mercantile Bancorp »

FJ Capital Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

WSC

WillScot

$17.10

-0.05 (-0.29%)

17:10
09/21/18
09/21
17:10
09/21/18
17:10
Syndicate
Breaking Syndicate news story on WillScot »

WillScot files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DTEA

DAVIDsTEA

$2.50

-0.9 (-26.47%)

17:09
09/21/18
09/21
17:09
09/21/18
17:09
Hot Stocks
Breaking Hot Stocks news story on DAVIDsTEA »

TDM Asset Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NYT

New York Times

$23.45

0.3 (1.30%)

, EXPE

Expedia

$133.73

-0.77 (-0.57%)

17:08
09/21/18
09/21
17:08
09/21/18
17:08
Hot Stocks
Expedia president Bhutani joins New York Times board »

The New York Times…

NYT

New York Times

$23.45

0.3 (1.30%)

EXPE

Expedia

$133.73

-0.77 (-0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBTX

Independent Bank

$67.60

-1.15 (-1.67%)

, GBNK

Guaranty Bancorp

$30.20

-0.5 (-1.63%)

17:08
09/21/18
09/21
17:08
09/21/18
17:08
Conference/Events
Guaranty Bancorp to host special shareholder meeting »

Special Shareholder…

IBTX

Independent Bank

$67.60

-1.15 (-1.67%)

GBNK

Guaranty Bancorp

$30.20

-0.5 (-1.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

MPC

Marathon Petroleum

$83.37

1.44 (1.76%)

, ANDV

Andeavor

$154.80

2.19 (1.44%)

17:01
09/21/18
09/21
17:01
09/21/18
17:01
Conference/Events
Andeavor to host special shareholder meeting »

Special Shareholder…

MPC

Marathon Petroleum

$83.37

1.44 (1.76%)

ANDV

Andeavor

$154.80

2.19 (1.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 24

    Sep

ANDV

Andeavor

$154.80

2.19 (1.44%)

, MPC

Marathon Petroleum

$83.37

1.44 (1.76%)

16:59
09/21/18
09/21
16:59
09/21/18
16:59
Conference/Events
Marathon Petroleum to host special shareholder meeting »

Special Shareholder…

ANDV

Andeavor

$154.80

2.19 (1.44%)

MPC

Marathon Petroleum

$83.37

1.44 (1.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

EPRT

Essential Properties Realty Trust

$14.49

-0.015 (-0.10%)

16:45
09/21/18
09/21
16:45
09/21/18
16:45
Hot Stocks
Breaking Hot Stocks news story on Essential Properties Realty Trust »

Integrated Core…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBSI

Barrett Business

$63.67

0.04 (0.06%)

16:43
09/21/18
09/21
16:43
09/21/18
16:43
Hot Stocks
SEC says Barrett Business to pay $1.5M penalty over improper accounting »

The Securities and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIGA

Siga Technologies

$7.25

0.5 (7.41%)

16:42
09/21/18
09/21
16:42
09/21/18
16:42
Conference/Events
Siga Technologies to host business news update conference call »

Management holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

SPY

SPDR S&P 500 ETF Trust

$292.03

-0.1774 (-0.06%)

, USO

United States Oil Fund

$14.95

0.145 (0.98%)

16:36
09/21/18
09/21
16:36
09/21/18
16:36
General news
Weekly CFTC Commitment of Traders highlights »

S&P500 net long 0.1K…

SPY

SPDR S&P 500 ETF Trust

$292.03

-0.1774 (-0.06%)

USO

United States Oil Fund

$14.95

0.145 (0.98%)

GLD

SPDR Gold Trust

$113.48

-0.77 (-0.67%)

FXE

Euro Currency Trust

$112.55

-0.27 (-0.24%)

FXC

CurrencyShares Canadian Dollar Trust

$76.37

-0.09 (-0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.